Krka’s management relies on determination, responsibility and clear vision to guide the workforce to deliver on the company’s goals and mission. Complex business processes are dealt with in a transparent manner, which requires close and intensive cooperation of employees.

Krka’s corporate governance is based on a two-tier system. The Management Board runs the company, while its operations are controlled by the Supervisory Board. Corporate governance is based on the legislation of the Republic of Slovenia, Slovenian and international good practice, the publicly available Corporate Governance Policy of the company and its internal rules.

Jože Colarič
President of the Management Board and CEO

Aleš Rotar
Member of the Management Board and Director of Pharmaceutical Development and Production

Vinko Zupančič
Member of the Management Board and Director of API Development, Production and Supply

David Bratož
Member of the Management Board

Milena Kastelic
Member of the Management Board – Worker Director; Deputy Director of Pharmaceutical Production in charge of the corresponding segment


Borut Lekše
Deputy CEO for legal affairs
and Head of Legal Affairs

Gregor Redek
Assistant Chief Executive

Breda Barbič Žagar
Medical Director

Matej Bašelj
Technical Director

Brane Kastelec
Director of Finance

Mojca Vidmar Berus
Director of Corporate Performance Management

Suzana Kolenc
Director of New Products

Mateja Vrečer
Director of Quality Management

Andrej Petrišič
Director of Information Technology

Dori Silvija Gorenc
Director of Human Resources

Elizabeta Suhadolc
Director of Marketing and Director of Pharmaceuticals

Alenka Jerman
Deputy Director of Marketing and Deputy Director of Pharmaceuticals

Samo Komel
Director of Non-Prescription Products

Rok Hrženjak
Director of Animal Health

Miha Borsellino
Director of Sales

Damjan Možina
Deputy Director of Sales and Region East Europe

Tomaž Sever
Deputy Director of Sales and Director of Region Central Europe

Miran Bevec
Deputy Director of Sales for the Russian Federation and Director of Key Market Russian Federation

Andrej Klobučar
Director of Region South-East Europe

Boštjan Korošec
Director of Region West Europe and Director of Key Market West Europe

Matjaž Zavolovšek
Director of Region Overseas Markets

Gordana Hren
Director of Key Market Croatia

Tomaž Indihar
Director of Key Market Poland

Jan Gala
Director of Key Market Czech Republic

Balázs Kollár
Director of Key Market Hungary

Vadim Kolesnikov
Director of Key Market Ukraine

Marjan Vrbnjak
Director of Key Market Slovakia

Davor M. Kalin
Director of Key Market Germany

Zvone Simončič
Director of Pharmaceutical R&D

Valentina Zaletel Mišmaš
Director of Pharmaceutical Production

Andrej Bavdek
Director of API Production

Mira Rataj Siročić
Head of Internal Audit

Teja Lesjak
Head of Public Relations

Barbara Kunič
Head of Industrial Property

Jože Žaren
Head of Safety and Health

Boris Fakin
Head of Public Services

Mojca Prah Klemenčič
Director of Region Slovenia and Director of Key Market Slovenia

Jože
Colarič

President of the Management Board and CEO

Dr. Aleš
Rotar

Member of the Management Board and Director of Pharmaceutical R&D and Production

Dr. Vinko
Zupančič

Member of the Management Board and Director of API R&D, Production and Supply Chain

David
Bratož

Member of the Management Board

Milena
Kastelic

Member of the Management Board – Worker Director; Deputy Director of Pharmaceutical Production

Jože
Mermal

President of the Supervisory Board

Prof. dr. Matej
Lahovnik

Deputy President of the Supervisory Board

Dr. Boris
Žnidarič

President of the Human Resource Committee

Mojca
Osolnik Videmšek

President of the Audit Committee

Franc
Šašek

Deputy President of the Supervisory Board

Continue browsing

Multiparty banner 1

DEVELOPMENT STRATEGY

The five-year Krka Group Development Strategy serves as the blueprint for our future operations.

MORE

INTERNATIONAL PRESENCE

Our products are available worldwide.

MORE

SUSTAINABILITY

We can only consider ourselves successful when our success has a positive impact on the environment and the community.

MORE